Biocon, Mylan launch cancer drug in Canada

Fulphila, co-developed by Biocon Biologics and Mylan, was the first
biosimilar pegfilgrastim to be approved in the US and was launched in
July 2018.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biocon-mylan-launch-cancer-drug-in-canada/articleshow/75434205.cms

Comments

Post a Comment

Popular posts from this blog

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission

Image
Biotecnika Times – Tata Innovation Fellowship 2021, NCCS PhD Admission Tata Innovation Fellowship 2021 For Life Sciences & Biotechnology – Download Biotecnika App to Apply Tata Innovation Fellowship 2021-22 – Biological, Life Sciences & Biotechnology. Interested and eligible applicants can check out all of the details on the same below NCCS PhD Admission 2022 March […] The post Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission appeared first on BioTecNika. http://dlvr.it/SBDQJZ
Read more

TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online

Image
TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online. MSc Biological Sciences Apply. Interested and eligible applicants can check out all of the details on the same below This job expires in   Job Opening RA-06 (All applicants must list this number in their application to be considered) The […] The post TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online appeared first on BioTecNika. http://dlvr.it/SDX14q
Read more